CD19 and B-cell chronic lymphocytic leukemia: To identify the possible cell source of TL1A, first we analyzed specific TL1A mRNA expression in different cell subsets (CD3+, CD14+, CD19+) isolated by FACS from PBMCs of CLL patients and healthy donors.